The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome these resistances, drugs with novel modes of action are urgently needed.

As more and more bacteria develop resistance to the drugs designed to kill them, a new study has found that even a relatively new antibiotic isn’t immune. Researchers have uncovered a gene ...

Antibiotic resistance is a growing problem, and it’s one that large pharmaceutical companies have largely abandoned. Some startups are filling the gap, and a new one, ArrePath, has novel molecules ...

Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers have discovered a new so-called lantibiotic, namely epilancin A37.